Advanced wound management demands biomaterials that simultaneously provide structural support and resist premature enzymatic degradation within protease-rich wound microenvironments. Notwithstanding the widespread use of type I collagen in tissue engineering, owing to its biocompatibility, uncross‑linked collagen scaffolds degrade rapidly in protease‑rich wound environments. In contrast, conventional chemical cross‑linkers improve stability, but often introduce cytotoxicity and hinder cell migration. To address this limitation, this study presents a sustainable strategy that valorises slaughterhouse by-products by blending chicken skin derived type I collagen and buffalo tracheal cartilage derived chondroitin sulphate with glycerol, agarose and Tween 80 to fabricate novel collagen-chondroitin sulphate (CCS) composite scaffolds. Since wound environments are dominated by matrix metalloproteinases (MMPs), especially collagenase, in vitro degradation studies were performed using collagenase incubation. Enzymatic stability of scaffolds was assessed by incubating pre-weighed (W0) scaffold pieces (2 cm × 2 cm, n = 6 per group) in 10 mL of phosphate-buffered saline (PBS, pH 7.4) containing 0.1 mg/mL of collagenase type I at 37°C for 24 hours. The enzymatic reaction was terminated by adding ethylenediaminetetraacetic acid (EDTA). The degraded scaffolds were thoroughly rinsed with deionised water, dried completely and re-weighed (Wf). The percentage of weight loss was calculated as: Weight loss (%) = [(W₀ – Wf) / W₀] × 100. Collagen-specific degradation was quantified by measuring hydroxyproline content in the supernatant using the chloramine-T/DMAB colorimetric method. Statistical comparison between groups was performed using Student’s unpaired two-tailed t-test in SPSS (version 20.0) software, with P < 0.05 considered as significant and P < 0.01 as highly significant. Following 24 hours of incubation, the collagen scaffolds exhibited a mean weight loss of 10.77 ± 1.23%, while the CCS scaffolds showed a significantly reduced loss of 7.75 ± 0.34% (t = 2.354; P < 0.05), representing a 28% reduction in bulk material loss attributable to CS incorporation. Hydroxyproline analysis revealed an even more pronounced protective effect at the molecular level: collagen degradation in collage scaffolds was 3.71 ± 0.26%, compared to just 2.08 ± 0.22% in CCS scaffolds (t = 4.646; P ≤ 0.01), a 44% reduction which is highly significant. Notably, no chemical cross-linker was employed in either scaffold formulation. This enhanced biostability may be attributed to the spontaneous electrostatic complexation between the negatively charged sulphate groups of chondroitin sulphate and the positively charged residues along the collagen triple helix, which creates a natural molecular shield that sterically and electrostatically hinders collagenase access to susceptible cleavage sites in collagen. In conclusion, this study demonstrates that incorporating chondroitin sulphate into collagen derived from chicken skin confers significant, cross-linker-free collagenase resistance, while successfully transforming low-value slaughterhouse by-products into a clinically relevant biomimetic material for advanced wound healing applications.